Overview
Luteinizing Hormone is a glycoprotein hormone secreted by the anterior pituitary gland under the control of hypothalamic gonadotropin-releasing hormone. It belongs to the group of gonadotropins along with follicle-stimulating hormone and human chorionic gonadotropin due to its direct action on the gonads. Luteinizing hormone plays a vital role in the reproductive system of both males and females and functions through feedback mechanisms regulated by sex hormones. Its primary role is to support the development and maintenance of gonadal tissues and normal reproductive function.
Role and Significance
Luteinizing hormone works together with follicle-stimulating hormone to regulate the menstrual cycle in females. It triggers ovulation, supports corpus luteum formation, and stimulates progesterone production, which is essential for maintaining pregnancy. It also contributes to hormone production required for normal sexual development in children and fertility in adults. In males, luteinizing hormone stimulates Leydig cells in the testes to produce testosterone. The hormone is secreted in a pulsatile manner, which is important for its normal physiological action.
Indications
Luteinizing hormone testing is indicated during fertility evaluation and in cases of menstrual cycle disorders. It is used to assess the health and function of reproductive organs such as ovaries and testes, and to evaluate pituitary gland function. The test is helpful in diagnosing early or delayed puberty in children and in assessing menopausal status in women. It is also commonly used in conditions such as polycystic ovary syndrome, abnormal vaginal or menstrual bleeding, irregular or absent periods, hot flushes, night sweats, and in individuals with underdeveloped or absent testes. Evaluation is also recommended in cases of very early onset of sexual characteristics or delayed puberty.
Causes
Abnormal luteinizing hormone levels may result from disturbances at the hypothalamic, pituitary, or gonadal level. Low levels can be associated with hypothalamic suppression, pituitary disorders, genetic conditions, systemic illness, stress, excessive exercise, malnutrition, or the use of exogenous sex steroids and certain medications. High levels are commonly seen in conditions such as polycystic ovary syndrome, primary ovarian insufficiency, menopause, hyperthyroidism, gonadal dysgenesis, and certain pituitary tumors. In some situations, elevated values may also be seen due to physiological changes such as puberty, pregnancy-related laboratory interference, or withdrawal of hormone therapy.
Risk Factors
Risk factors influencing luteinizing hormone levels include hormonal imbalance, pituitary or hypothalamic dysfunction, chronic systemic illness, genetic disorders affecting reproductive development, and the use of hormonal medications such as contraceptives or hormone replacement therapy. Pulsatile secretion and diurnal variation of the hormone can affect the interpretation of results. Laboratory-specific reference ranges and assay methods also influence accuracy, making proper clinical correlation essential.
Prevention
Prevention of misinterpretation of luteinizing hormone levels depends on appropriate test timing, correct sample collection, and clinical correlation. Blood samples should be collected and processed carefully to avoid hemolysis, and in women, samples are preferably taken during the early follicular phase when menstrual cycle assessment is required. Awareness of factors such as medications, hormonal therapy, and physiological variations helps ensure accurate interpretation. Proper evaluation supports timely diagnosis and effective management of reproductive and endocrine disorders.
